Dual-task Cycling System on Cognitive Function for the Elderly

NCT ID: NCT05384639

Last Updated: 2022-05-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-27

Study Completion Date

2022-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project aims to develop a new dual-task stationary cycling system that can monitor and provide feedback on the aerobic exercise intensity, while administrating appropriate cognitive trainings targeting various cognitive sub domains through a screen in front of the user.

The proposed system is designed to train the brain with cognitive tasks and the body with aerobic exercises at the same time. The difficulties of the cognitive tasks are controlled by the users' previous performances on these tasks so that they wouldn't be too easy nor too difficult. Similarly, the intensity of the aerobic exercise will be monitored through an optical encoder for the cycling cadence, two power meters for the force output on the two pedals, as well as a heart rate monitor for the users' physiological response. Constant feedback is being provided to the users so that they will exercise at the correct intensity to provide the greater cardiovascular and cognitive benefits.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cognitive Impairment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dual-task Group

Group Type EXPERIMENTAL

Dual-task Group

Intervention Type DEVICE

Participant will cycle and perform cognitive training simultaneously.

Cycling Group

Group Type ACTIVE_COMPARATOR

Cycling Group

Intervention Type DEVICE

Participant will cycle only.

Cognitive Group

Group Type ACTIVE_COMPARATOR

Cognitive Group

Intervention Type DEVICE

Participant will perform cognitive training only.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dual-task Group

Participant will cycle and perform cognitive training simultaneously.

Intervention Type DEVICE

Cycling Group

Participant will cycle only.

Intervention Type DEVICE

Cognitive Group

Participant will perform cognitive training only.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of MCI or cutoff at 2 \< n \< 16 th percentile MoCA score according to the level of education and age
* Sufficient cognitive ability to follow simple instructions
* Able to understand content and purpose of the study
* Conscious and in stable physical condition

Exclusion Criteria

* Any additional medical or psychological condition that would affect their ability to comply with the study protocol, e.g., a significant orthopaedic or chronic pain condition; or
* Severe hip, knee or ankle contracture that would preclude the passive range of motion of the leg
* Uncontrolled Cardiac issues
Minimum Eligible Age

65 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Innovation and Technology Commission, Hong Kong

OTHER

Sponsor Role collaborator

Chinese University of Hong Kong

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Raymond KY Tong

Professor and Chairman

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Raymond Tong, PhD

Role: PRINCIPAL_INVESTIGATOR

Department of Biomedical Engineering, The Chinese University of Hong Kong

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Biomedical Engineering, The Chinese University of Hong Kong

Shatin, , Hong Kong

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Hong Kong

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Raymond Tong, PhD

Role: CONTACT

+85239438454

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Raymond Tong, PhD

Role: primary

+852 3943 8454

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020.319

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.